In this Issue:
Daclatasvir + sofosbuvir: high cure rate in HCV GT3
HCV clearance and remission of mixed cryoglobulinaemia
HCV-mediated premature T cell ageing
HCV genotype-specific regulation of lipoprotein metabolism
HCV disrupts P-body granule formation
How host cells recognise HCV to initiate interferon signalling
Continue entecavir indefinitely in HBeAg-negative HBV
Simeprevir + sofosbuvir effective in HCV with cirrhosis
HLA-DP polymorphisms linked to HBsAg levels and seroclearance
Hepatitis E virus and fulminant hepatitis
Please login below to download this issue (PDF)